A Preliminary Study of Prophylactic Fentanyl Sublingual Spray for Exercise-Induced Breakthrough Dyspnea
Phase of Trial: Phase II/III
Latest Information Update: 29 Jan 2018
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain; Dyspnoea
- Focus Therapeutic Use
- 22 Jan 2018 Planned End Date changed from 1 Jan 2020 to 1 Jan 2021.
- 22 Jan 2018 Status changed from active, no longer recruiting to recruiting.
- 17 Jan 2018 Planned End Date changed from 1 Jan 2019 to 1 Jan 2020.